Editas Medicine Stock (NASDAQ: EDIT)
|Day Range12.38 - 12.95||52 Wk Range9.59 - 27.99||Open / Close12.73 / 12.95||Float / Outstanding61.3M / 68.7M|
|Vol / Avg.1.6M / 1.7M||Mkt Cap890.1M||P/E-||50d Avg. Price15.62|
|Div / Yield-||Payout Ratio-||Total Float61.3M||EPS-0.78|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Editas Medicine (NASDAQ: EDIT) through any online brokerage.
The latest price target for Editas Medicine (NASDAQ: EDIT) was reported by B of A Securities on Thursday, September 29, 2022. The analyst firm set a price target for 18.00 expecting EDIT to rise to within 12 months (a possible 39.00% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Editas Medicine (NASDAQ: EDIT) is $12.95 last updated Today at October 4, 2022, 8:00 PM UTC.
There are no upcoming dividends for Editas Medicine.
Editas Medicine’s Q3 earnings are confirmed for Monday, November 7, 2022.
There is no upcoming split for Editas Medicine.
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.